Literature DB >> 17545740

Diabetes and parkinsonian signs in older persons.

Zoe Arvanitakis1, Robert S Wilson, Julia L Bienias, David A Bennett.   

Abstract

We examined the relation of type 2 diabetes mellitus to parkinsonian signs in older persons. Participants were 1030 women and men (mean age 80.3 y, education 14.5 y, Mini-Mental State Examination 27.9) without dementia or Parkinson disease, enrolled in the Rush Memory and Aging Project, an epidemiologic study of aging. We used separate linear and logistic regression models, adjusted for age, sex, and education, to examine the relation of diabetes, identified by history and medication inspection, to each of the scores of global parkinsonian signs and 4 separate parkinsonian signs. Diabetes was present in 140 (14%) participants. Most participants had mild parkinsonian signs. Diabetes was associated with a more severe global parkinsonian signs score (beta=0.20, SE=0.10, P=0.05) and postural reflex impairment-gait disturbance (beta=0.40, SE=0.17, P=0.02), but not with bradykinesia, rigidity, or tremor. Associations were no longer significant after controlling for vascular risk factors or conditions, particularly body mass index and congestive heart failure. Overall, there was no evidence that vascular variables modified the relation of diabetes to parkinsonian signs. In summary, we found that diabetes was associated with parkinsonian signs, especially postural reflex impairment-gait disturbance, and that vascular factors may play a role in this association.

Entities:  

Mesh:

Year:  2007        PMID: 17545740     DOI: 10.1097/WAD.0b013e31805ba768

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  15 in total

Review 1.  Diabetes type II: a risk factor for depression-Parkinson-Alzheimer?

Authors:  Peter Riederer; Jasmin Bartl; Gerd Laux; Edna Grünblatt
Journal:  Neurotox Res       Date:  2010-06-15       Impact factor: 3.911

2.  Overview and findings from the rush Memory and Aging Project.

Authors:  David A Bennett; Julie A Schneider; Aron S Buchman; Lisa L Barnes; Patricia A Boyle; Robert S Wilson
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

3.  Advanced age, cardiovascular risk burden, and timed up and go test performance in Parkinson disease.

Authors:  Vikas Kotagal; Roger L Albin; Martijn L T M Müller; Robert A Koeppe; Stephanie Studenski; Kirk A Frey; Nicolaas I Bohnen
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-05-26       Impact factor: 6.053

4.  Insulin resistance impairs nigrostriatal dopamine function.

Authors:  J K Morris; G L Bomhoff; B K Gorres; V A Davis; J Kim; P-P Lee; W M Brooks; G A Gerhardt; P C Geiger; J A Stanford
Journal:  Exp Neurol       Date:  2011-06-15       Impact factor: 5.330

Review 5.  Loss of motor function in preclinical Alzheimer's disease.

Authors:  Aron S Buchman; David A Bennett
Journal:  Expert Rev Neurother       Date:  2011-05       Impact factor: 4.618

Review 6.  Convergent Molecular Pathways in Type 2 Diabetes Mellitus and Parkinson's Disease: Insights into Mechanisms and Pathological Consequences.

Authors:  Sandeep Xxxx; Mir Hilal Ahmad; Linchi Rani; Amal Chandra Mondal
Journal:  Mol Neurobiol       Date:  2022-05-16       Impact factor: 5.590

Review 7.  Brain insulin dysregulation: implication for neurological and neuropsychiatric disorders.

Authors:  Rasoul Ghasemi; Leila Dargahi; Ali Haeri; Maryam Moosavi; Zahurin Mohamed; Abolhassan Ahmadiani
Journal:  Mol Neurobiol       Date:  2013-01-20       Impact factor: 5.590

8.  Quantitative brain measurements in community-dwelling elderly persons with mild parkinsonian signs.

Authors:  Elan D Louis; Adam M Brickman; Charles DeCarli; Scott A Small; Karen Marder; Nicole Schupf; Truman R Brown
Journal:  Arch Neurol       Date:  2008-12

9.  Diabetes and the risk of developing Parkinson's disease in Denmark.

Authors:  Eva Schernhammer; Johnni Hansen; Kathrine Rugbjerg; Lene Wermuth; Beate Ritz
Journal:  Diabetes Care       Date:  2011-03-16       Impact factor: 19.112

10.  Slow walking speed and cardiovascular death in well functioning older adults: prospective cohort study.

Authors:  Julien Dumurgier; Alexis Elbaz; Pierre Ducimetière; Béatrice Tavernier; Annick Alpérovitch; Christophe Tzourio
Journal:  BMJ       Date:  2009-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.